ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ITRM Iterum Therapeutics PLC

1.56
-0.02 (-1.27%)
Última actualización: 14:34:29
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Iterum Therapeutics PLC ITRM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -1.27% 1.56 14:34:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.58 1.52 1.63 1.58
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202407:00GLOBEIterum Therapeutics Resubmits New Drug Application to U.S...
28/3/202406:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
28/3/202406:00GLOBEIterum Therapeutics Reports Fourth Quarter and Full Year..
21/3/202415:30GLOBEIterum Therapeutics to Report Fourth Quarter and Full Year..
15/3/202407:00GLOBEIterum Therapeutics to Participate in H.C. Wainwright..
06/3/202407:16EDGAR2Form 8-K - Current report
06/3/202407:00GLOBEIterum Therapeutics Provides Business Update
30/1/202416:00EDGAR2Form 8-K - Current report
30/1/202406:15EDGAR2Form 8-K - Current report
30/1/202406:00PRNUSIterum Therapeutics Announces Positive Topline Results from..
29/12/202315:30EDGAR2Form 8-K - Current report
14/12/202306:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/12/202306:30EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202316:15EDGAR2Form PRE 14A - Other preliminary proxy statements
04/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202307:30EDGAR2Form 8-K - Current report
04/12/202307:00GLOBEIterum Therapeutics Regains Compliance with Nasdaq Bid Price..
07/11/202307:30GLOBEIterum Therapeutics to Provide Business Update and Report..
24/10/202308:00EDGAR2Form 8-K - Current report
24/10/202307:00GLOBEIterum Therapeutics Announces Completion of Enrollment in..
12/10/202308:15GLOBEIterum Therapeutics to Present Data at IDWeek 2023
11/8/202306:15EDGAR2Form 8-K - Current report
11/8/202306:00GLOBEIterum Therapeutics Reports Second Quarter 2023 Financial..
04/8/202316:00GLOBEIterum Therapeutics to Provide Business Update and Report..
01/8/202315:16EDGAR2Form 8-K - Current report
13/7/202306:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/7/202308:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/7/202308:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/6/202317:23GLOBEIterum Therapeutics to Present Data at ASM Microbe 2023
12/5/202306:00GLOBEIterum Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock